Shenzhen Meili Namikong Technology Co., Ltd. announced that it has raised tens of millions in a round of funding on April 26, 2023. The transaction included participation from new investor, Autobio Diagnostics Co., Ltd.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.36 CNY | -0.98% |
|
-1.63% | -18.68% |
21/05 | Autobio Diagnostics' Unit Gets Nod for Two Products | MT |
19/04 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.68% | 374.07Cr | |
-10.34% | 1.16TCr | |
-12.48% | 737.49Cr | |
+31.15% | 544.24Cr | |
+0.26% | 530.74Cr | |
+7.43% | 257.81Cr | |
-64.53% | 233.43Cr | |
+27.01% | 222.83Cr | |
-11.15% | 220.67Cr | |
-16.74% | 166.58Cr |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Shenzhen Meili Namikong Technology Co., Ltd. announced that it has received funding from Autobio Diagnostics Co., Ltd.